T7修饰的纳米声敏剂通过调控胞内铁稳态促进口腔鳞状细胞癌铁死亡的机制研究

批准号:
32000516
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
李楠
依托单位:
学科分类:
细胞衰老、死亡及自噬
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
李楠
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
声动力治疗在口腔鳞状细胞癌(OSCC)无创治疗中极具有应用价值。但5-ALA在体稳定性差和肿瘤组织靶向能力不足,限制了其抗肿瘤效果及临床转化应用。本项目拟利用可降解黑磷纳米片作为输送载体,修饰T7小分子多肽构建靶向OSCC的纳米声敏剂递送系统,实现5-ALA高效靶向给药,提高声动力治疗OSCC的效果,并阐明基于纳米声敏剂的声动力治疗通过激活铁自噬释放Fe2+调控细胞内铁稳态,促进OSCC发生铁死亡的分子机理。建立一种精准高效靶向OSCC的声敏剂纳米递送体系,为探索高效声动力治疗OSCC方案提供理论依据和新思路。
英文摘要
Sonodynamic therapy was valuable in noninvasive treatment of oral squamous cell carcinoma (OSCC). However, the unstable of 5-ALA in vivo and the insufficient targeting ability of tumor tissues limit its anti-tumor effect and clinical translational application. This project intends to use biodegradable black phosphate as nano-transmission carrier and modifying T7 small molecule polypeptide to build nano-sonosensitizer delivery system targeted OSCC, to achieve 5-ALA efficient targeted drug delivery and improve the antitumor effect in the treatment of OSCC. Clarifying the molecular mechanism of that based on nano- sonosensitizer sonodynamic therapy can release Fe2 +by activating ferritinophagy to regulation cell iron homeostasis to promote ferropotosis of OSCC. A nano-delivery system of sonosensitizer targeting OSCC with high accuracy and efficiency was established to provide theoretical basis and new ideas for the exploration of high-efficiency sonodynamic treatment of OSCC.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:--
发表时间:2022
期刊:标记免疫分析与临床
影响因子:--
作者:范海东;郑雨燕;李楠
通讯作者:李楠
国内基金
海外基金
